T1	Treatment 79 125	erlotinib and docetaxel versus docetaxel alone
T2	Treatment 242 308	Concomitant administration of erlotinib with standard chemotherapy
T3	Treatment 578 601	erlotinib and docetaxel
T4	Treatment 802 912	sequential erlotinib 150 mg/d (day 2-16)+docetaxel (75 mg/m(2) d1) (arm ED) or docetaxel (75 mg/m(2) d1) alone
T5	Treatment 1173 1175	ED
T6	Treatment 1388 1394	The ED
T7	Treatment 1465 1471	arm ED
T8	Treatment 1529 1542	arms ED and D
T9	Treatment 1630 1675	CONCLUSION Sequential erlotinib and docetaxel
T10	Treatment 1699 1719	than docetaxel alone
